Boston Scientific (BSX) Other financing activities (2019 - 2026)

Boston Scientific has disclosed Other financing activities across 8 years of filings, most recently posting $5.0 million for Q2 2026.

• In Q2 2026, Other financing activities fell 84.38% year-over-year to $5.0 million; the TTM figure through Jun 2026 stood at $221.0 million (down 18.45% YoY), while the FY2025 annual figure was $282.0 million, up 22.61% from the prior year.
• Other financing activities came in at $5.0 million for Q2 2026 at Boston Scientific, down from $81.0 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $115.0 million in Q1 2025 to a low of $5.0 million in Q2 2026.
• Average Other financing activities over 5 years is $50.9 million, with a median of $42.0 million recorded in 2022.
• Year-over-year, Other financing activities soared 350.0% in 2023 and tumbled 84.38% in 2026.
• Over 5 years, Other financing activities stood at $19.0 million in 2022, then retreated by 10.53% to $17.0 million in 2023, then soared by 64.71% to $28.0 million in 2024, then declined by 28.57% to $20.0 million in 2025, then plunged by 75.0% to $5.0 million in 2026.
• Per Business Quant data, the three most recent Other financing activities figures were $5.0 million in Q2 2026, $81.0 million in Q1 2026, and $20.0 million in Q4 2025.